SINGAPORE (May 27): RHB Group Research is keeping “neutral” on Singapore Medical Group (SMG) but with a lowered target price of 25 cents from 35 cents previously, as uncertainties are still present.

In a Tuesday report, analyst Lee Cai Ling and Jarick Seet says, “Travel restrictions and closure of the aesthetic business due to the Government’s Circuit Breaker has impacted Singapore Medical Group.”

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook